EFFECIENCY OF THE IMPLEMENTATION OF THE LOCAL PROTOCOL OF MEDICAL ASSISTANCE TO THE PATIENTS WITH EPIDERMAL DYSPLASIA OF THE SKIN IN A MULTIDISCIPLINARY MEDICAL FACILITY

Oshyvalova O. O.

SOCIAL MEDICINE AND ORGANIZATION OF HEALTHCARE PROTECTION

Scentific article

According to the data of National cancer-register of Ukraine for 2014-2015 in the structure of incidence of malignant skin neoplasms non-melanoma skin cancers occupied the second place among women and the third among men. In view of the absence as at 2015 of the current regulatory framework and medical-technological documents with the provision of medical care for actinic keratosis (AK), non-invasive (SCCis) and invasive (cSCC) forms of squamous cell carcinoma of the skin in Ukraine it was logical to create medical-technological documents of local significance. Objective of the research is to substantiate, develop and implement local protocol of medical assistance (LPMA) to the patients with AK, SCCis, cSCC in a multidisciplinary medical facility. Methods. International databases of clinical protocols on high standards of scientific quality in the development of local protocols providing medical care to patients with АК, SCCis, cSCC were used for the implementation of the objectives. The implementation of the protocols was made in State Scientific Institution “Scientific and Practical Centre of Preventive and Clinical Medicine” of the State Administration (SSI) in 2015-2018. Results. Comparing the incidence rates of the affiliated contingent SSI AK, SCCis, cSCC after the implementation of LPDA (2015-2018) with similar indicators before the implementation of LPDA (2011-2014) it should be noted that the incidence rate of AK significantly increased (p≤0.05) with the stabilization of the incidence of SCCis and cSCC (p = 0.05 and p = 0.04 respectively). Analysis of the performance criteria revealed that the implementation of the LPDA over 4 years has reliably influenced the increase in the effectiveness of the criterion «achieved remission» in patients with AK, as well as in patients with SCCis, cSCC (p≤0.001, p≤0.02 and p≤0.01 respectively), and the reduction of the criterion «progression of the disease» for skin pathology (р≤0,01, р≤0,01, p≤0,05). Conclusions. The use of LPDA is an opportunity to introduce modern medical diagnostic and treatment methods in its own medical practice, the effectiveness of which is proved by numerous controlled studies, thereby increasing the quality and effectiveness of providing medical care to patients.

medical-technological documents, local protocol of medical assistance, epidermal dysplasia of the skin, actinic keratosis, squamous cell carcinoma

1. National Cancer Registry of Ukraine: short description of the database as of January, 2018. Available from: http://www.ncru.inf.ua/ publications/index.htm
2. Nakaz MOZ Ukrainy vid 28.12.2002 r. № 507 «Pro zatverdzhennia normatyviv nadannia medychnoi dopomohy ta pokaznykiv yakosti medychnoi dopomohy» (iz zminamy vid 16.07.2014 r.). Dostupno: http://zakon.rada. gov.ua/rada/show/ru/v0507282-02 [in Ukrainian].
3. Nakaz MOZ Ukrainy vid 07.06.2004 r. № 286 «Pro udoskonalennia dermatovenerolohichnoi dopomohy naselenniu Ukrainy» (iz zminamy vid 04.07.2016). Dostupno: https://zakon.rada.gov.ua/rada/show/v0286282-04 [in Ukrainian].
4. Nakaz MOZ Ukrainy vid 17.09.2007 № 554 «Pro zatverdzhennia protokoliv nadannia medychnoi dopomohy za spetsialnistiu «onkolohiia». Dostupno: http://mozdocs. kiev.ua/view.php?id=9118 [in Ukrainian].
5. Nakaz MOZ Ukrainy vid 30.12.1992 № 208 «Pro zakhody podalshoho pokrashchennia i rozvytku onkolohichnoi dopomohy naselenniu». Dostupno: http://old. moz.gov.ua/ua/print/dn_20110104_p.html [in Ukrainian].
6. Nakaz MOZ Ukrainy vid 28.09.2012 № 751 «Pro stvorennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy v systemi Ministerstva okhorony zdorov`ia Ukrainy». Dostupno: https://zakon.rada.gov. ua/laws/show/z2001-12 [in Ukrainian].
7. «Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy khvorym na atopichnyi dermatyt. Dostupno: http://mtd.dec. gov.ua/index.php/uk/haluzevi-standarty-ta-klinichni-nastanovy [in Ukrainian].
8. «Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy khvorym na buloznyi epidermoliz». Dostupno: http://mtd.dec.gov. ua/index.php/uk/haluzevi-standarty-ta-klinichni-nastanovy [in Ukrainian].
9. «Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy khvorym na melanomu». Dostupno: http://mtd.dec.gov.ua/index. php/uk/haluzevi-standarty-ta-klinichni-nastanovy [in Ukrainian].
10. «Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy khvorym na bazalnoklitynnu kartsynomu». Dostupno: http://mtd.dec.gov.ua/index.php/uk/haluzevi-standarty-ta-klinichni-nastanovy [in Ukrainian].
11. Unifikovana metodyka z rozrobky lokalnykh protokoliv medychnoi dopomohy dlia zakladiv okhorony zdorov`ia Ukrainy, metodychni rekomendatsii. Kyiv; 2012. s. 38. [in Ukrainian].
12. Evidence and consensus based (S3) Guidelines for the Treatment of Actinic Keratosis International League of Dermatological Societies (ILDS) in cooperation with the European Dermatology Forum (EDF), 2015. Available from: https://www. ncbi.nlm.nih.gov/pubmed/26370093
13. Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality/ USA. 2015. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4588356/
14. Actinic Keratosis: Rationale and Management»/Australia, 2014. Available from: https://www. ncbi.nlm.nih.gov/pmc/articles/PMC4588356/
15. Аctinic keratoses – also known as solar keratoses/ United Kingdom, 2013. Available from: http://www.bad.org.uk/shared/get-file. ashx?id=1974&itemtype=document
16. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease)»/ United Kingdom, 2014. Available from: http://www.bad.org.uk/libraryedia/documents/SCC_in_situ_guidelines_2014.pdf
17. Guidelines for management of squamous cell carcinoma in situ (Bowen's disease), 2013. Available from: https://www.cochranelibrary.com/ cdsr/doi/10. 1002/14651858. CD007281pub2/epdf/full
18. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Available from: http://www.eado.org/medias/Content/Files/2015-Stratigos-EurGuidelineSCC-EJC.pdf
19. Management of primary cutaneous squamous cell carcinoma / А national clinical guideline)/ June 2014. Available from: https://www.sign. ac.uk/assets/sign140.pdf
20. Evidence-based Guideline on Prevention of Skin Cancer /Germany, 2014. Available from: https://www.leitlinienprogramm-onkologie.de/ fileadmin/_migrated/ content_ uploads/Short_version_-_Guideline_on_prevention_of_skin_cancer.pdf
21. Prevention of skin cancer: clinical practice Guideline; 2013. Available from: https://www.albertahealthservices.ca/assets/info/hp/cancer/ if-hp-cancer-guide-cu014-prevention.pdf
22. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Association of Dermatologists: Guideline Clearing Report»/United Kingdom, 2009. Available from: http://www.bad.org.uk/ librarymedia%5Cdocuments%5CSCC_2009.pdf
23. Non-melanoma Skin Cancer: Guidelines for Treatment and Management in Australia: Guideline»/Australia, 2009. Available from: https:// www.clinicalguidelines.gov.au/

«Bulletin of problems biology and medicine» Issue 1 Part 1 (148), 2019 year, 307-313 pages, index UDK 616.5-006-005.552.3

10.29254/2077-4214-2019-1-1-148-307-313